Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Edoxaban versus warfarin in patients with atrial fibrillation.
N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19.
N Engl J Med. 2013.
PMID: 24251359
Free article.
Clinical Trial.
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy.
Andrade JG, Deyell MW, Macle L, Wells GA, Bennett M, Essebag V, Champagne J, Roux JF, Yung D, Skanes A, Khaykin Y, Morillo C, Jolly U, Novak P, Lockwood E, Amit G, Angaran P, Sapp J, Wardell S, Lauck S, Cadrin-Tourigny J, Kochhäuser S, Verma A; EARLY-AF Investigators.
Andrade JG, et al.
N Engl J Med. 2023 Jan 12;388(2):105-116. doi: 10.1056/NEJMoa2212540. Epub 2022 Nov 7.
N Engl J Med. 2023.
PMID: 36342178
Clinical Trial.
Item in Clipboard
Evaluation of the artus® Prep&Amp UM RT-PCR for detection of SARS-CoV-2 from nasopharyngeal swabs without prior nucleic acid eluate extraction.
O'Hara RW, Brown B, Hughes A, McEwan A, Birtles A, Hawker A, Davies E, Farooq HZ, Tilston P, Haigh D, Hesketh L, Dodgson A, Dodgson K, Shazaad A, Guiver M, Machin N.
O'Hara RW, et al.
J Clin Virol Plus. 2022 Aug;2(3):100098. doi: 10.1016/j.jcvp.2022.100098. Epub 2022 Jul 16.
J Clin Virol Plus. 2022.
PMID: 35874465
Free PMC article.
The total invalid rate of specimens was 7.34% due to a lack of detectable RNase P (C(t) >35). The artus SARS-CoV-2 Prep&Amp UM RT-PCR assay is a new rapid RT-PCR assay, which may be considered to produce acceptable levels of diagnostic sensitivity and specifi …
The total invalid rate of specimens was 7.34% due to a lack of detectable RNase P (C(t) >35). The artus SARS-CoV-2 Prep& …
Item in Clipboard
Cite
Cite